Acute Myeloid Leukemia (AML) remains one of the most challenging hematological malignancies to treat, with relapse and refractory cases continuing to pose significant hurdles ...

As the dengue virus continues to be a significant global health concern, an international research team led by Duke-NUS ...

Immunotherapeutic approaches have substantially improved the treatment of patients with advanced malignancies. However, most ...

Nonpathogenic E. coli displaying decoy-resistant IL18 demonstrate potent anti-tumor responses and boost CAR-NK cell ...

Visos teisės saugomos. © 2024 UAB „Lrytas“. Kopijuoti, dauginti, platinti galima tik gavus raštišką UAB „Lrytas“ sutikimą.

So-called high-dose flu vaccines are available for older people. The reason: their immune system does not always respond ...

The risk of COVID might have lessened, but long COVID remains a worry for many people. Researchers are looking for risk ...

Autumn is a time of change - not only for nature, but also for our bodies. Cooler temperatures and the transition from summer ...

Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of ...

Human innate immune cells that “remember” previous stimulation could provide new insights into chronic inflammatory diseases.

Immune cells used for adoptive immune cell therapy, originate from the patients themselves (autologous) or from someone other than the patient (allogenic). These immune cells must have a receptor ...